Targeting AKT/PKB to improve treatment outcomes for solid tumors.

Iida, M

Targeting AKT/PKB to improve treatment outcomes for solid tumors. [electronic resource] - Mutation research - 111690 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

1873-135X

10.1016/j.mrfmmm.2020.111690 doi


3-Phosphoinositide-Dependent Protein Kinases--genetics
Antineoplastic Agents--therapeutic use
Clinical Trials as Topic
DNA Damage
DNA Repair--drug effects
DNA, Neoplasm--genetics
Gamma Rays--therapeutic use
Gene Expression Regulation, Neoplastic
Humans
Isoenzymes--antagonists & inhibitors
Molecular Targeted Therapy--methods
Neoplasms--enzymology
Phosphatidylinositol 3-Kinases--genetics
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins c-akt--antagonists & inhibitors
Signal Transduction
Treatment Outcome
ras Proteins--genetics